Abstract

Dendritic cells (DCs) play a central role in the orchestration of effective T cell responses against tumors. However, their functional behavior is context-dependent. DC type, transcriptional program, location, intratumoral factors, and inflammatory milieu all impact DCs with regard to promoting or inhibiting tumor immunity. The following review introduces important facets of DC function, and how subset and phenotype can affect the interplay of DCs with other factors in the tumor microenvironment. It will also discuss how current cancer treatment relies on DC function, and survey the myriad ways with which immune therapy can more directly harness DCs to enact antitumor cytotoxicity.

Original languageEnglish
Article number1393451
JournalFrontiers in immunology
Volume15
DOIs
StatePublished - 2024

Keywords

  • antigen presentation
  • cancer immune therapy
  • cancer vaccination
  • dendritic cell (DC)
  • dendritic cell subtypes
  • dendritic cell targeting
  • dendritic cell vaccine
  • tumor neoantigen

Fingerprint

Dive into the research topics of 'Dendritic cell subsets and implications for cancer immunotherapy'. Together they form a unique fingerprint.

Cite this